Chen Katz
- Cancer Research top 5%
- Carcinogens and Genotoxicity Assessment 3
- Chemical Health and Safety top 10%
- Oncology top 10%
- Cancer-related Molecular Pathways 9
- Molecular Biology top 10%
- Cell death mechanisms and regulation 6
- Ubiquitin and proteasome pathways 4
- Epigenetics and DNA Methylation 3
- RNA modifications and cancer 3
-
- Cancer Research and Treatments 3
-
- Advanced Glycation End Products research 3
- Co-authors
- Benjamin L. Van DuurenAndrew SivakAssaf FriedlerB. M. GoldschmidtI SeidmanSusan MelchionneEliora Z. RonShahar Rotem‐Bamberger
- Journals
- JNCI Journal of the National Cancer Institute (7 papers)Proceedings of the National Academy of Sciences (4 papers)PLoS ONE (3 papers)
- Partner nations
- IsraelUnited StatesNetherlands
In The Last Decade
Chen Katz
41 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 109
- Cancer Research 324
- Chemical Health and Safety 11
- Oncology 382
- Molecular Biology 930
- Health, Toxicology and Mutagenesis 141
Countries citing papers authored by Chen Katz
This map shows the geographic impact of Chen Katz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chen Katz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chen Katz more than expected).
Fields of papers citing papers by Chen Katz
This network shows the impact of papers produced by Chen Katz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chen Katz. The network helps show where Chen Katz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chen Katz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 2 | |
| 3 | 2023 | 19 | |
| 4 | 2022 | 3 | |
| 5 | 2021 | 6 | |
| 6 | 2021 | 29 | |
| 7 | 2018 | 106 | |
| 8 | 2013 | 15 | |
| 9 | 2012 | 173 | |
| 10 | 2012 | 33 | |
| 11 | 2011 | 153 | |
| 12 | 2011 | 25 | |
| 13 | 2010 | 128 | |
| 14 | 2009 | 8 | |
| 15 | 2009 | 19 | |
| 16 | 2008 | 35 | |
| 17 | 2005 | 13 | |
| 18 | Dose-response studies with a pure tumor-promoting agent, phorbol myristate acetate. | 1973 | 61 |
| 19 | Replication of low-level carcinogenic activity bioassays. | 1972 | 6 |
| 20 | 1971 | 29 |
About Chen Katz
Chen Katz is a scholar working on Oncology, Clinical Biochemistry, Endocrinology, Process Chemistry and Technology and Biotechnology, having authored 41 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (9 papers), Cell death mechanisms and regulation (6 papers), Ubiquitin and proteasome pathways (4 papers), Cancer Research and Treatments (3 papers), Carcinogens and Genotoxicity Assessment (3 papers), Epigenetics and DNA Methylation (3 papers), RNA modifications and cancer (3 papers) and Advanced Glycation End Products research (3 papers). The work is most often cited by research in Cancer Research (324 citations), Chemical Health and Safety (11 citations), Oncology (382 citations), Molecular Biology (930 citations) and Health, Toxicology and Mutagenesis (141 citations). Chen Katz has collaborated with scholars based in Israel, United States and Netherlands. Frequent co-authors include Benjamin L. Van Duuren, Andrew Sivak, Assaf Friedler, B. M. Goldschmidt, I Seidman, Susan Melchionne, Eliora Z. Ron, Shahar Rotem‐Bamberger, Stefan Rüdiger and Carol Prives. Their work appears in journals such as JNCI Journal of the National Cancer Institute, Proceedings of the National Academy of Sciences, PLoS ONE, Vaccine and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.